SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|
| FROBEN TAB 100MG | 100 mg | Tablet · Oral use | 100 Blister | SAR 90.40 | NCE · Prescription | RECKITT BENCKISER HEALTHCARE INTERNATIONAL | Invalid · Not Marketed |
| FROBEN TAB 100MG | 100 mg | Tablet · Oral use | 30 Blister | SAR 30.50 | NCE · Prescription | RECKITT BENCKISER HEALTHCARE INTERNATIONAL | Invalid · Not Marketed |
| FROBEN TAB 50MG | 50 mg | Tablet · Oral use | 100 Blister | SAR 49.30 | NCE · Prescription | RECKITT BENCKISER HEALTHCARE INTERNATIONAL | Invalid · Not Marketed |
| FROBEN TAB 50MG | 50 mg | Tablet · Oral use | 30 Blister | SAR 20.70 | NCE · Prescription | RECKITT BENCKISER HEALTHCARE INTERNATIONAL | Invalid · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|
| FLURBIPROFEN SODIUM | 0.03% | solution/drops · ophthalmic | BAUSCH AND LOMB | Prescription | 4 Jan 1995 |
| FLURBIPROFEN | 100MG | tablet · oral | GENUS | Prescription | 31 May 1995 |
| OCUFEN | 0.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution/drops · ophthalmic | ALLERGAN | Discontinued | 31 Dec 1986 |
| ANSAID | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | PHARMACIA AND UPJOHN | Discontinued | 31 Oct 1988 |
| FLURBIPROFEN | 50MG; 100MG | tablet · oral | NATCO PHARMA | Discontinued | 20 Jun 1994 |
| FLURBIPROFEN | 100MG; 50MG | tablet · oral | TEVA | Discontinued | 24 May 1995 |
| FLURBIPROFEN | 50MG; 100MG | tablet · oral | IVAX SUB TEVA PHARMS | Discontinued | 31 May 1995 |
| FLURBIPROFEN | 50MG; 100MG | tablet · oral | RISING | Discontinued | 28 Jul 1995 |
| FLURBIPROFEN | 50MG; 100MG | tablet · oral | PLIVA | Discontinued | 1 Apr 1997 |
| FLURBIPROFEN | 100MG | tablet · oral | THERAGEN | Discontinued | 16 May 1997 |
| FLURBIPROFEN | 50MG; 100MG | tablet · oral | SUN PHARM INDS INC | Discontinued | 27 Apr 2001 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|
| FLURBIPROFEN | 01912038 | 100 MG | TABLET · ORAL | AA PHARMA INC |
| FLURBIPROFEN | 01912046 | 50 MG | TABLET · ORAL | AA PHARMA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|
| US NADAC | FLURBIPROFEN 0.03% EYE DROP | $9.8292 | per ML | 23 Sep 2026 |
| US NADAC | FLURBIPROFEN 100 MG TABLET | $3.17335 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Flurbiprofen 100mg tablets | £107.00 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Flurbiprofen 2.92mg/actuation oromucosal spray sugar free | £5.17 | 15 ml | 1 Oct 2026 |
| NHS Drug Tariff | Flurbiprofen 50mg tablets | £60.54 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Flurbiprofen 8.75mg lozenges | £4.52 | 16 lozenge | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.